Healthcare provider profile · identity verified

Mahrukh Subhani, M.D.

Internal Medicine · BLOOMINGDALE, IL · NPI 1841369279

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	500	142
Atorvastatin Calcium	Atorvastatin Calcium	479	148
Metformin Hcl	Metformin Hcl	392	105
Amlodipine Besylate	Amlodipine Besylate	358	112
Losartan Potassium	Losartan Potassium	314	79
Rosuvastatin Calcium	Rosuvastatin Calcium	259	78
Lisinopril	Lisinopril	236	75
Omeprazole	Omeprazole	230	86
Alprazolam	Alprazolam	149	32
Pantoprazole Sodium	Pantoprazole Sodium	149	53
Azithromycin	Azithromycin	144	116
Gabapentin	Gabapentin	143	53
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	136	32
Jardiance	Empagliflozin	133	29
Simvastatin	Simvastatin	129	35
Metoprolol Succinate	Metoprolol Succinate	125	43
Albuterol Sulfate Hfa	Albuterol Sulfate	122	57
Hydrochlorothiazide	Hydrochlorothiazide	121	41
Fluticasone Propionate	Fluticasone Propionate	112	43
Enalapril Maleate	Enalapril Maleate	106	30
Glimepiride	Glimepiride	106	23
Famotidine	Famotidine	90	28
Januvia	Sitagliptin Phosphate	85	18
Metoprolol Tartrate	Metoprolol Tartrate	85	23
Zolpidem Tartrate	Zolpidem Tartrate	85	35
Carvedilol	Carvedilol	84	27
Diclofenac Sodium	Diclofenac Sodium	81	28
Tamsulosin Hcl	Tamsulosin Hcl	81	20
Triamcinolone Acetonide	Triamcinolone Acetonide	76	32
Alendronate Sodium	Alendronate Sodium	73	24
Glipizide	Glipizide	66	20
Ozempic	Semaglutide	65	14
Escitalopram Oxalate	Escitalopram Oxalate	64	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	45
Lovastatin	Lovastatin	58	16
Tramadol Hcl	Tramadol Hcl	57	22
Clopidogrel	Clopidogrel Bisulfate	53	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	14
Metformin Hcl Er	Metformin Hcl	51	18
Pravastatin Sodium	Pravastatin Sodium	50	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	49	42
Glipizide Er	Glipizide	49	12
Alcohol Pads	Alcohol Antiseptic Pads	48	suppressed
Furosemide	Furosemide	46	15
Irbesartan	Irbesartan	44	15
Clonazepam	Clonazepam	43	11
Ezetimibe	Ezetimibe	43	12
Methylprednisolone	Methylprednisolone	43	33
Glyburide	Glyburide	42	suppressed
Meloxicam	Meloxicam	42	21
Atenolol	Atenolol	40	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	39	17
Sertraline Hcl	Sertraline Hcl	38	18
Fenofibrate	Fenofibrate Nanocrystallized	37	12
Cephalexin	Cephalexin	34	27
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	33	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	32	14
Dropsafe Prep Pads	Alcohol Antiseptic Pads	31	suppressed
Ibandronate Sodium	Ibandronate Sodium	30	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	30	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	11
Mirtazapine	Mirtazapine	29	suppressed
Potassium Chloride	Potassium Chloride	29	suppressed
Tradjenta	Linagliptin	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Finasteride	Finasteride	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	12
Montelukast Sodium	Montelukast Sodium	27	suppressed
Pro Comfort Alcohol Pads	Alcohol Antiseptic Pads	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Eliquis	Apixaban	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Ibuprofen	Ibuprofen	24	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Amoxicillin	Amoxicillin	23	21
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	18
Valsartan	Valsartan	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Trazodone Hcl	Trazodone Hcl	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	13
Allopurinol	Allopurinol	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Pregabalin	Pregabalin	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Spironolactone	Spironolactone	18	suppressed
Linzess	Linaclotide	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Nystatin	Nystatin	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	14	suppressed
Naproxen	Naproxen	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Prednisone	Prednisone	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Procto-Med Hc	Hydrocortisone	13	suppressed
Cefdinir	Cefdinir	12	12
Donepezil Hcl	Donepezil Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Tobramycin	Tobramycin	12	11
Azelastine Hcl	Azelastine Hcl	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Restasis	Cyclosporine	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error